ALLAN C SILBER
CIK 1009161 · Executive Chairman · last filed 2023-12-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.57M
Companies
3
Total Filings
35
Lifetime Open-Market Net
-$2.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc. (PNT) Delisted | Executive Chairman | 4,268,605 | $12.50 | $53.36M | $311.2K | 5 | 2023-12-27 |
| HGBL | 10%+ Owner | 3,598,215 | $1.27 | $4.57M | -$2.51M | 7 | 2021-09-03 |
| POINT Biopharma Global Inc. (RACA) Delisted | Director | 8,254,260 | $10.27 | $84.81M | $0 | 1 | 2021-06-30 |
Recent Filings · Page 4 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-09-14 | — | Buy (P) | +13,207 | $17.0K | |
| 2012-09-06 | — | Buy (P) | +250 | $275 | |
| 2012-09-04 | — | Buy (P) | +1 | $1 | |
| 2012-08-30 | — | Buy (P) | +318 | $350 | |
| 2011-06-30 | — | Grant (A) | — | $0 |
Showing 31–35 of 35
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.